Suppressive mechanisms of EPA on human T cell proliferation

被引:21
|
作者
Terada, S
Takizawa, M
Yamamoto, S
Ezaki, O
Itakura, H
Akagawa, KS
机构
[1] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan
[2] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan
[3] Natl Inst Hlth & Nutr, Div Clin Nutr, Shinjuku Ku, Tokyo 1628636, Japan
[4] Univ Tokushima, Sch Med, Dept Nutr, Tokushima 7708503, Japan
关键词
EPA; human T cell; IL-2; H2O2;
D O I
10.1111/j.1348-0421.2001.tb02647.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In vivo and in vitro experiments show that polyunsaturated fatty acids (PUFAs) including eicosapentaenoic acid (EPA) inhibit mitogen- or antigen-stimulated proliferation of T cells in rodents and humans. However, the exact manner and mechanisms by which PUFA inhibits T cell proliferation is not clear. In the present study, we investigated the suppressive effects of EPA, an n-3 PUFA, on PHA stimulated human peripheral blood T cells, Our results showed that EPA suppresses mitogen- or antigen-stimulated human T cell proliferation by at least 2 steps; step 1) EPA suppresses T cell proliferation by inhibiting IL-2R alpha expression and IL-2 production; step 2) EPA induces cell death of blast T cells without reducing the expression of IL-2R alpha. We also showed that EPA selectively stimulates the cell death of blast T cells but not resting T cells, The suppressive effect of EPA was mediated via the production of reactive oxygen products, because EPA-stimulated H2O2 production and the suppressive effect of EPA was restored by addition of catalase or NAG. These results taken together suggest that such immunosuppressive effects of EPA may explain the apparent benefits of EPA-enriched diets for patients with inflammatory disorders.
引用
收藏
页码:473 / 481
页数:9
相关论文
共 50 条
  • [31] Molecular mechanisms of human T-cell differentiation
    Lahesmaa, Riitta
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 8 - 8
  • [32] The effects and mechanisms of Pyridostigmine on cell proliferation and fibrosis of human cardiac fibroblasts
    Lishui, S.
    Xiaoli, L.
    Guilin, S.
    Guoming, D.
    Dong, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 622 - 622
  • [33] IDENTIFICATION OF A COSTIMULATORY FACTOR FOR HUMAN T-CELL PROLIFERATION
    ABOLHASSANI, M
    CHIAO, JW
    CANCER LETTERS, 1991, 56 (01) : 71 - 76
  • [34] Substrate Rigidity Regulates Human T Cell Activation and Proliferation
    O'Connor, Roddy S.
    Hao, Xueli
    Shen, Keyue
    Bashour, Keenan
    Akimova, Tatiana
    Hancock, Wayne W.
    Kam, Lance C.
    Milone, Michael C.
    JOURNAL OF IMMUNOLOGY, 2012, 189 (03): : 1330 - 1339
  • [35] The role of human β-defensin 2 in T cell activation and proliferation
    Chen, D.
    George, J.
    Rowley, D.
    Outram, S.
    IMMUNOLOGY, 2014, 143 : 62 - 63
  • [36] In vitro infection with HCV increases the suppressive phenotype and activity of the human regulatory T cell
    Ouaguia, L.
    Morales, O.
    Senechal, M.
    Wychowski, C.
    Carpentier, A.
    Aoudjehane, L.
    Calmus, Y.
    de Launoit, Y.
    Conti, F.
    Delhem, N.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 3 - 3
  • [37] Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments
    Shenoy, Gautam N.
    Bhatta, Maulasri
    Loyall, Jenni L.
    Raymond, J. Kelleher, Jr.
    Bernstein, Joel M.
    Bankert, Richard B.
    IMMUNOLOGICAL INVESTIGATIONS, 2020, 49 (07) : 726 - 743
  • [38] A Population of Suppressive Monocytes Inhibiting T Cell Proliferation and Dendritic Cell Differentiation in Relapsed Non-Hodgkin's Lymphoma
    Lin, Yi
    Bulur, Peggy A.
    Gustafson, Michael P.
    Witzig, Thomas E.
    Dietz, Allan B.
    BLOOD, 2008, 112 (11) : 300 - 300
  • [39] Mechanisms of polyploid cell proliferation
    Basto, R.
    Budzyk, M.
    Budzyk, M.
    Gemble, S.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 124 - 124
  • [40] Suppressive Effect of Chemically Induced Hypoxia on Glioblastoma Cell Proliferation
    Kholodenko, I. V.
    Yarygin, K. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 175 (4) : 530 - 534